公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) | Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 19 | 15 | |
2021 | Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study | Liou B.-H.; HSIN-YUN SUN ; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG ; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG ; the Taiwan HIV Study Group | Infectious Diseases and Therapy | 3 | 2 | |
2016 | Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections | Lin S.-Y.; Huang C.-H.; Ko W.-C.; Chen Y.-H.; PO-REN HSUEH | Expert Opinion on Pharmacotherapy | 7 | 5 | |
2015 | Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007 | Jean S.-S.; Lee W.-S.; Bai K.-J.; Lam C.; Hsu C.-W.; Yu K.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 12 | 9 | |
2013 | Reply to altshuler et al | Lee N.-Y.; Lee C.-C.; Li C.-W.; PO-REN HSUEH ; Ko W.-C. | Clinical Infectious Diseases | 3 | 3 | |
2020 | A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs | Chen P.-L.; Lee N.-Y.; Cia C.-T.; Ko W.-C.; PO-REN HSUEH | Frontiers in Pharmacology | 45 | 37 | |
2016 | RNA polymerase B subunit gene mutations in?biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment | Tang H.-J.; Lai C.-C.; PO-REN HSUEH ; Chen C.-C.; Wu K.-Y.; Lin Y.-C.; Zhang C.-C.; Weng T.-C.; Chiu Y.-H.; Toh H.-S.; Chiang S.-R.; Yu W.-L.; Ko W.-C.; Chuang Y.-C. | Journal of Microbiology, Immunology and Infection | 9 | 9 | |
2012 | The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens | Chen Y.-H.; Ko W.-C.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 24 | 19 | |
2012 | Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan | Lau Y.-J.; Chen Y.-H.; Huang C.-T.; Lee W.-S.; Liu C.-Y.; Liu J.-W.; Liu H.-D.; Lee Y.-J.; Chen C.-W.; Ko W.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 10 | 11 | |
2017 | Role of rifampin for the treatment of bacterial infections other than mycobacteriosis | Lee C.-Y.; Huang C.-H.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; PO-REN HSUEH | Journal of Infection | 19 | 17 | |
2020 | SARS-CoV-2 and COVID-19 | WANG-HUEI SHENG ; Ko W.-C.; Huang Y.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 10 | 7 | |
2021 | Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study | Huang, Sung-Hsi; Lee, Chun-Yuan; Tsai, Chin-Shiang; Tsai, Mao-Song; Liu, Chun-Eng; Hsu, Wei-Ting; Chen, Hong-An; WANG-DA LIU ; Yang, Chia-Jui; HSIN-YUN SUN ; Ko, Wen-Chien; Lu, Po-Liang; Lee, Yuan-Ti; CHIEN-CHING HUNG ; YU-SHAN HUANG ; SUI-YUAN CHANG ; Taiwan HIV Study Group; Chen L.-Y.; Zhang J.-Y.; Chang H.-Y.; Liu W.-C.; Su Y.-C.; Wang N.-C.; Lin T.-Y.; KUAN-YIN LIN ; Yang C.-J.; Chen H.-A.; Tsai M.-S.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YI-CHIA HUANG ; Huang S.-H.; Lee Y.-T.; Lin J.-J.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Chen G.-J.; Lin C.-Y.; Hung T.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Tsai C.-S.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Lee C.-Y.; Chen Y.-H.; Lee C.-H.; Tsai H.-C.; Che T.-C.; Taiwan HIV Study Group | Infectious diseases and therapy | 1 | 1 | |
2009 | Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination | HSIN-YUN SUN ; Ko W.-C.; Tsai J.-J.; Lee H.-C.; Liu C.-E.; Wong W.-W.; Su S.-C.; Ho M.-W.; Cheng S.-H.; Yang C.-H.; Lin Y.-H.; Miao W.-J.; WANG-HUEI SHENG ; CHIEN-CHING HUNG | American Journal of Gastroenterology | 31 | 30 | |
2014 | Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan | HSIN-YUN SUN ; Cheng C.-Y.; Lee N.-Y.; Yang C.-J.; Liang S.-H.; Tsai M.-S.; Ko W.-C.; Liu W.-C.; Wu P.-Y.; Wu C.-H.; Lin H.-H.; CHIEN-CHING HUNG | PLoS ONE | 20 | 21 | |
2020 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges | Lai C.-C.; Shih T.-P.; Ko W.-C.; Tang H.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 3839 | 2509 | |
2012 | A solitary facial tumor with erosion on an 81-year-old oriental woman | Ko W.-C.; Hung C.-M.; TSEN-FANG TSAI | Indian Journal of Dermatology, Venereology and Leprology | 1 | 1 | |
2022 | Species identification and antifungal susceptibility of uncommon blood yeast isolates | Li M.-C.; Tang H.-J.; Wu C.-J.; Wang S.-W.; Su S.-L.; Liu W.-L.; Ko W.-C.; YEE-CHUN CHEN | Journal of Microbiology, Immunology and Infection | 6 | 3 | |
2020 | Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012–2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018–2019 | Jean S.-S.; Ko W.-C.; PO-REN HSUEH ; SMART Study Group | International Journal of Antimicrobial Agents | 6 | 6 | |
2019 | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: Results from surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Lai C.-C.; Chen Y.-S.; Lee N.-Y.; Tang H.-J.; Lee S.S.-J.; Lin C.-F.; Lu P.-L.; Wu J.-J.; Ko W.-C.; Lee W.-S.; PO-REN HSUEH | Infection and Drug Resistance | 22 | 20 | |
2003 | Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Lee C.-M.; Huang W.-K.; Wu T.-L.; Wan J.-H.; Yang D.; Shyr J.-M.; Chuang Y.-C.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 32 | 26 | |